Abnormal Involuntary Movement Scale (AIMS)
Measures involuntary movements of tardive dyskinesia (TD).
- Rate highest severity observed. Rate movements that occur upon activation one less than those observed spontaneously.
- Complete the examination procedure prior to making ratings. Note that the total AIMS score is not reported to the patient.
Advice
- If there is evidence of TD:
- Evaluate the necessity of continued antipsychotic treatment and consider dose reduction or switching to a medication with a lower risk of TD.
- Discuss the potential use of pharmacologic agents, such as vesicular monoamine transporter 2 (VMAT2) inhibitors, for symptomatic management.
- Collaborate with neurology or psychiatry for complex cases or if symptoms are severe.
- If no evidence of TD:
- Continue periodic monitoring to ensure early detection of potential movement disorders.
- Reinforce patient and caregiver education on recognizing signs of involuntary movements.
-
The APA notes:
-
There is no specific threshold score that suggests a need for intervention.
-
The same total score can be associated with different clinical manifestations and varying impacts on different patients.
-
-
Therefore, the use of this tool should be combined with clinical judgment, a thorough clinical examination, and patient input.
- For more detailed management recommendations, refer to the APA practice guideline for the treatment of patients with schizophrenia.